Engineering CD4+ T Cells to Enhance Cancer Immunity
This review presents key advances in combining T cell receptor (TCR) gene transfer to redirect T-cell specificity with gene engineering in order to enhance cancer-protective immune function. We discuss how emerging insights might be applied to CD4+ T cells. Although much attention has been paid to t...
Main Authors: | Francesca Sillito, Angelika Holler, Hans J. Stauss |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1721 |
Similar Items
-
The Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
by: Ghada A. Soliman
Published: (2013-06-01) -
Implications of a ‘Third Signal’ in NK Cells
by: Mohamed Khalil, et al.
Published: (2021-07-01) -
Rapamycin Maintains the Chondrocytic Phenotype and Interferes with Inflammatory Cytokine Induced Processes
by: Andrea De Luna-Preitschopf, et al.
Published: (2017-07-01) -
The Role of Trogocytosis in the Modulation of Immune Cell Functions
by: Kensuke Miyake, et al.
Published: (2021-05-01) -
Transient Inhibition of mTORC1 Signaling Ameliorates Irradiation-Induced Liver Damage
by: Wuping Yang, et al.
Published: (2019-03-01)